SANDMAN PAUL W received a stock award from PDL BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/12/2018ACC: 0000882104-18-000062
+54.35K
Net shares
Net buyer
$150.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
54.35K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+54.35K
Price / share
$2.76
Trade value
$150K
% of position
26.1%
6/8/2018
208.45K→262.80K
Total
Net shares
+54.35K
Net value
$150K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 6/8/2018 | A · Award | +54.35K | $2.76 | $150K | 26.1% | 208.45K | 262.80K |
| Total | +54.35K | $150K | ||||||
Derivative Transactions0
No derivative transactions reported